Skip to content
ORAORAORA303030

Drawing based on the label description. No photo yet.

“Orapred ODT: (prednisolone sodium phosphate orally disintegrating tablets) 40.3 mg prednisolone sodium phosphate (equivalent to 30 mg prednisolone base) is a white, flat faced, beveled tablet, debossed with ORA on one side and 30 on the other”

ORA 30 pill

Pill with imprint ORA 30 is white, round, 6 mm and has been identified as Prednisolone Sodium Phosphate 30 mg. It is used for swelling from fluid buildup, adrenal insufficiency and multiple sclerosis. It is supplied by Advanz Pharma (Us) Corp.

Prednisolone Sodium Phosphate 30 mg

Imprint
ORA 30
Strength
30 mg
Used for
Swelling from fluid buildup, adrenal insufficiency and multiple sclerosis
Color
White
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet, orally disintegrating
Manufacturer
Advanz Pharma (Us) Corp
Drug class
Steroid (corticosteroid)
NDC
59212-702, 59212-702-06, 59212-702-48, 59212-702-12, 50742-385, 50742-385-06, 50742-385-12

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Prednisolone pills and guides

What is Prednisolone used for?

Prednisolone is used for swelling from fluid buildup, adrenal insufficiency, multiple sclerosis and ankylosing spondylitis.

Medicine type
Steroid (corticosteroid)
Official uses from the US prescribing label

1. Endocrine disorders. Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance).

Congenital adrenal hyperplasia

Nonsuppurative thyroiditis

Hypercalcemia associated with cancer

2. Rheumatic disorders. As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:

Psoriatic arthritis

Rheumatoid arthritis; including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy)

Ankylosing spondylitis

Acute and subacute bursitis

Acute nonspecific tenosynovitis

Acute gouty arthritis

Post-traumatic osteoarthritis

Synovitis of osteoarthritis

Epicondylitis

3. Collagen diseases. During an exacerbation or as maintenance therapy in selected cases of:

Systemic lupus erythematosus

Acute rheumatic carditis

Systemic dermatomyositis (polymyositis)

4. Dermatologic diseases

Pemphigus

Bullous dermatitis herpetiformis

Severe erythema multiforme (Stevens-Johnson syndrome)

Exfoliative dermatitis

Mycosis fungoides

Severe psoriasis

Severe seborrheic dermatitis

5. Allergic states. Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment:

Seasonal or perennial allergic rhinitis

Serum sickness

Bronchial asthma

Contact dermatitis

Atopic dermatitis

Drug hypersensitivity reactions

6. Ophthalmic diseases. Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as:

Allergic conjunctivitis

Keratitis

Allergic corneal marginal ulcers

Herpes zoster ophthalmicus

Iritis and iridocyclitis

Chorioretinitis

Anterior segment inflammation

Diffuse posterior uveitis and choroiditis

Optic neuritis

Sympathetic ophthalmia

7. Respiratory diseases

Symptomatic sarcoidosis

Loeffler's syndrome not manageable by other means

Berylliosis

Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy

Aspiration pneumonitis

8. Hematologic disorders

Idiopathic thrombocytopenic purpura in adults

Secondary thrombocytopenia in adults

Acquired (autoimmune) hemolytic anemia

Erythroblastopenia (RBC anemia)

Congenital (erythroid) hypoplastic anemia

9. Neoplastic diseases. For palliative management of:

Leukemias and lymphomas in adults

Acute leukemia of childhood

10. Edematous states. To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus.

11. Gastrointestinal diseases. To tide the patient over a critical period of the disease in:

Ulcerative colitis

Regional enteritis

12. Nervous system. Acute exacerbations of multiple sclerosis

13. Miscellaneous

Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy

Trichinosis with neurologic or myocardial involvement

From the FDA-approved label on DailyMed (published Jan 06, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows ORA and the other side shows 30.
  • It is white, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Orapred.

Ingredients

Active: Prednisolone Sodium Phosphate

Inactive: Citric Acid Monohydrate, Silicon Dioxide, Crospovidone, Hypromelloses, Magnesium Stearate, Mannitol, Dimethylaminoethyl Methacrylate - Butyl Methacrylate - Methyl Methacrylate Copolymer, Cellulose, Microcrystalline, Sodium Bicarbonate, Sucralose, Sucrose

Also distributed by

Ingenus Pharmaceuticals, LLC

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Prednisolone pills